drugset
Drugs / Sub/MF59
last change Feb 2008 re-read 2 minutes ago

Sub/MF59

also known as FLUAD

Vaccine

Developed for
influenza
Investigated by
Chiron s.r.l. Beijing Representative Office · Novartis · Novartis Vaccines

Trials 1 · a red edge is where a trial was stopped

today NCT00310648 · Ph 3
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00310648 Jan 2006 → ? influenza Novartis Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Sub/MF59 “an MF59-adjuvanted subunit influenza vaccine (Sub/MF59; FLUAD, Novartis Vaccines) was evaluated among elderly Chinese subjects” PMID 18289372 ↗ Feb 2008
Known as FLUAD “an MF59-adjuvanted subunit influenza vaccine (Sub/MF59; FLUAD, Novartis Vaccines) was evaluated among elderly Chinese subjects” PMID 18289372 ↗ Feb 2008
Modality Vaccine “an MF59-adjuvanted subunit influenza vaccine (Sub/MF59; FLUAD, Novartis Vaccines) was evaluated among elderly Chinese subjects” PMID 18289372 ↗ Feb 2008